Skip to content
Stop using now Drug recall · FDA · Published May 25, 2012

V Maxx Rx Recall: Unapproved Drug with Sulfoaildenafil

The Menz Club, LLC recalls V Maxx Rx All Natural Male Enhancement because it contains sulfoaildenafil, an unapproved drug analogue.

🇺🇸 FDA recall #D-1657-2012DrugV Maxx Rx ›
Take action

Contact the company

Recalling firmThe Menz Club, LLC103 W. Washington Street, Suite B5 · Ridgeland, MS 39157
✎ GovInfoNow plain-language explainer

The Menz Club, LLC is recalling V Maxx Rx, marketed as "All Natural Male Enhancement," because FDA testing found it contains sulfoaildenafil. This substance is an analogue of sildenafil, a prescription drug for erectile dysfunction, making the product an unapproved new drug. The recall covers approximately 585,000 capsules distributed nationwide. Read more at govinfonow.com/recall/48741-the-menz-club-llc-recalls-v-maxx-rx-all-natural.

Source Summary by GovInfoNow · govinfonow.com/recall/48741-the-menz-club-llc-recalls-v-maxx-rx-all-natural · Updated October 13, 2026 · FDA enforcement record: FDA #D-1657-2012

Cite this page

“V Maxx Rx Recall: Unapproved Drug with Sulfoaildenafil.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48741-the-menz-club-llc-recalls-v-maxx-rx-all-natural. Based on FDA recall #D-1657-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1657-2012%22&limit=1).

The FDA announced on May 25, 2012, that The Menz Club, LLC is recalling V Maxx Rx, All Natural Male Enhancement products nationwide. The agency stated the unapproved new drugs contain sulfoaildenafil, an analogue of sildenafil.

How to tell if you have it

  • V Maxx Rx, All Natural Male Enhancement
  • 1-count blister pack UPC Code 2802803561
  • 5-count blister pack UPC Code 0972859402
  • 10-count bottle UPC code 0913251017
  • Lot #s: 101108, 101009, 101010, 101011; 101108, 101109, 101110; 301000, 301001

The hazard

Samples tested by the FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction. This makes these products unapproved new drugs.

Context

GovInfoNow's records show The Menz Club, LLC has one other recall on record since March 10, 2012. On March 10, 2012, the company recalled Blue Male Enhancement Pills due to unapproved drug content. Other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (Dec. 15, 2025), SUN PHARMACEUTICAL Xyvona 3mg Tablets Recall (May 22, 2026), and Shoolin Pharma Chem Sildenafil Recall (Aug. 3, 2026).

How to tell if you have this one

Check your product packaging for the brand name "V Maxx Rx" or "All Natural Male Enhancement." Look for specific UPC codes: 2802803561 (1-count blister), 0972859402 (5-count blister), or 0913251017 (10-count bottle). Verify the lot numbers printed on the package, which include 101108, 101009, 101010, 101011, 101109, 101110, 301000, or 301001.

  • Brand
    V Maxx Rx
  • Product
    V Maxx Rx, All Natural Male Enhancement, a) 1-count blister pack UPC Code 2802803561; b) 5-count blister pack UPC Code
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Discontinue use of V Maxx Rx immediately due to the presence of unapproved sulfoaildenafil.

  2. Contact the manufacturer

    Call The Menz Club, LLC at 601-866-6746 for further instructions regarding the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.5 years after the firm started it.

1. Firm started the recall: May 25, 201212. FDA classified it Class I: Aug 20, 201223. Published in FDA’s Enforcement Report: Aug 29, 201234. FDA terminated the recall: Dec 7, 2015420122015
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1657-2012 (May 25, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1657-2012 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA